Viewing Study NCT00294749



Ignite Creation Date: 2024-05-05 @ 4:41 PM
Last Modification Date: 2024-10-26 @ 9:23 AM
Study NCT ID: NCT00294749
Status: TERMINATED
Last Update Posted: 2009-01-27
First Post: 2006-02-19

Brief Title: Short or Long Schemes of Antibiotic Prophylaxis for Prostate Biopsy
Sponsor: Poitiers University Hospital
Organization: Poitiers University Hospital

Study Overview

Official Title: Comparison Between Short and Long Schemes of Antibiotic Prophylaxis for Transrectal Prostate Biopsy A Multicentre Prospective Randomised Study
Status: TERMINATED
Status Verified Date: 2009-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to determine whether long antibiotic prophylactic is more effective than a short traitement in infective complications for prostate biopsy
Detailed Description: Prophylactic antibiotic is used to minimize the infective complications risk following transrectal biopsy of the prostate

The majority of works points to the need of antibiotic prophylaxis previously to transrectal prostate biopsy However there is a lot of controversy and diversity of therapeutic schemes in the literature concerning the ideal drug to be used and the time employed for infectious prophylaxis

The objective of this randomised study was to assess 2 different schemes of antimicrobial prophylaxis aiming to determine the difference in infective complications with a single dose of ciprofloxacin 2 hours before the procedure vs ciprofloxacin for 3 days

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None